[
  {
    "ts": null,
    "headline": "Trump's drug price order is part request, part threat: Analyst",
    "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747092000,
      "headline": "Trump's drug price order is part request, part threat: Analyst",
      "id": 134408474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f"
    }
  },
  {
    "ts": null,
    "headline": "How Trump could go about executing order to slash drug prices",
    "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747079446,
      "headline": "How Trump could go about executing order to slash drug prices",
      "id": 134408480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy",
    "summary": "We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected […]",
    "url": "https://finnhub.io/api/news?id=9a844c7fd266ebafed7c176061b2947f11904b807106efda734d8e5791cc3b7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747076759,
      "headline": "Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy",
      "id": 134408771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected […]",
      "url": "https://finnhub.io/api/news?id=9a844c7fd266ebafed7c176061b2947f11904b807106efda734d8e5791cc3b7e"
    }
  },
  {
    "ts": null,
    "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
    "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
    "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067695,
      "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
      "id": 134408773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
      "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7"
    }
  },
  {
    "ts": null,
    "headline": "Amazon.com Inc., Nike share gains lead Dow's 1150-point surge",
    "summary": "Amazon.com Inc., Nike share gains lead Dow's 1150-point surge",
    "url": "https://finnhub.io/api/news?id=79f12abb30ef200a83dbf4a0ab94f3065d90eab6fdd391ae62755d528dc19b61",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747060620,
      "headline": "Amazon.com Inc., Nike share gains lead Dow's 1150-point surge",
      "id": 134401433,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Amazon.com Inc., Nike share gains lead Dow's 1150-point surge",
      "url": "https://finnhub.io/api/news?id=79f12abb30ef200a83dbf4a0ab94f3065d90eab6fdd391ae62755d528dc19b61"
    }
  },
  {
    "ts": null,
    "headline": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
    "summary": "The \"Magnificent Seven,\" made up of Nvidia (NVDA), Alphabet (GOOG, GOOGL), Tesla (TSLA), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Apple (AAPL), are rallying after the US and China agreed to lower tariff rates for a 90-day period. Airline stocks, like American Airlines (AAL), Delta (DAL), and United Airlines (UAL), are also gaining on the trade deal. Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=9628fb9881b7e2d232cd96a73b7010b72d37c73ec467fc135e20ba0642e54e93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747058507,
      "headline": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
      "id": 134380086,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The \"Magnificent Seven,\" made up of Nvidia (NVDA), Alphabet (GOOG, GOOGL), Tesla (TSLA), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Apple (AAPL), are rallying after the US and China agreed to lower tariff rates for a 90-day period. Airline stocks, like American Airlines (AAL), Delta (DAL), and United Airlines (UAL), are also gaining on the trade deal. Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=9628fb9881b7e2d232cd96a73b7010b72d37c73ec467fc135e20ba0642e54e93"
    }
  },
  {
    "ts": null,
    "headline": "Amazon.com Inc., Nike share gains lead Dow's 1,033-point surge",
    "summary": "Amazon.com Inc., Nike share gains lead Dow's 1,033-point surge",
    "url": "https://finnhub.io/api/news?id=9d1a2c864205db9bed91b6aabf9f9ffc27ad3add58c5bc6586edb4733fc9f71f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747054740,
      "headline": "Amazon.com Inc., Nike share gains lead Dow's 1,033-point surge",
      "id": 134388388,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Amazon.com Inc., Nike share gains lead Dow's 1,033-point surge",
      "url": "https://finnhub.io/api/news?id=9d1a2c864205db9bed91b6aabf9f9ffc27ad3add58c5bc6586edb4733fc9f71f"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048140,
      "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "id": 134382834,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97"
    }
  },
  {
    "ts": null,
    "headline": "Pharma stocks recover from initial shock of Trump's drug pricing order",
    "summary": "Shares of U.S. drugmakers reboundedon Monday after an initial selloff as analysts said thatPresident Donald Trump's sweeping executive order to slashprescription drug prices would be difficult to...",
    "url": "https://finnhub.io/api/news?id=854f422de04d9d06592e646bb0047bf330f46fd78d3f3afbc1a7080421fa2757",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747051825,
      "headline": "Pharma stocks recover from initial shock of Trump's drug pricing order",
      "id": 134383921,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Shares of U.S. drugmakers reboundedon Monday after an initial selloff as analysts said thatPresident Donald Trump's sweeping executive order to slashprescription drug prices would be difficult to...",
      "url": "https://finnhub.io/api/news?id=854f422de04d9d06592e646bb0047bf330f46fd78d3f3afbc1a7080421fa2757"
    }
  },
  {
    "ts": null,
    "headline": "MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification",
    "summary": "Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=e1dec7a264b5da8f19a99c1384e3b7bfe141a6bcfd5cee703fec586f8b688a54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747042957,
      "headline": "MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification",
      "id": 134379340,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=e1dec7a264b5da8f19a99c1384e3b7bfe141a6bcfd5cee703fec586f8b688a54"
    }
  },
  {
    "ts": null,
    "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
    "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
    "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013223,
      "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
      "id": 134374993,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400200369/image_1400200369.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
      "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3"
    }
  }
]